OUR COMPANIES 

At Vesper we believe that a dedicated focus on a few, well selected, high potential companies is more effective than betting on a high number of cases with little dedication to each of them.

So far, we have managed to back several success stories. 

Vesper has transitioned towards a biotech focused venture builder since 2016. 

Aptah Biosciences SA

Drug Design

Biotech

01

Aptah Biosciences

Through Aptah's technology we are able to modulate the spliceosome machinery and thus, the pre-mRNA, which ensures the precise control of the transcription step and modulation of specific gene expression -not only silencing, but also editing the pre-mRNA by hacking the spliceosome machinery.

Founded in 2019 by Caio Bruno & Higor Falcão.

B2B

Early Stage - Seed

GnTech SA

Pharmacogenetics

Biotech + Big Data

02

GnTech

B2B2C

Software

Middle Stage - Series A

Founded in 2012 by Paula May & Guido May.

Brazilian leader in pharmacogenetics tests for central nervous system (CNS) based treatments, turning them more personalized and consequently more efficient.

Exact Sales SA

Outbound Sales

Software

03

Exact Sales

SAAS

B2B Sales

Middle Stage - Series A

Brazilian leader and pioneer in sales engagement software.

Founded in 2015 by Theo Orosco & Felipe Roman.

Welle Tecnologia Laser SA

Laser Machinery

Manufacturing

04

Welle Laser

HAAS

B2B Sales

Middle Stage - Series B

Brazilian leader in laser machinery.

* Welle is not in Vesper's portfolio today.

Founded in 2008 by Gabriel and Rafael Bottos.

© 2021 Vesper Ventures. All Rights Reserved.

Vesper_2_branca.png